IRADIMED CORP Files 8-K on Financials
Ticker: IRMD · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1325618
Sentiment: neutral
Topics: financial-reporting, 8-k, disclosure
Related Tickers: IRMD
TL;DR
IRMD filed an 8-K on Jan 10, 2025, reporting on financial condition. Details to follow.
AI Summary
On January 10, 2025, IRADIMED CORPORATION filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were disclosed in the provided text, but the filing indicates a report date of January 10, 2025.
Why It Matters
This 8-K filing signals that IRADIMED CORPORATION is providing updated financial information and operational details to the public and regulatory bodies.
Risk Assessment
Risk Level: low — This filing is a standard disclosure of financial information and does not inherently present new risks.
Key Players & Entities
- IRADIMED CORPORATION (company) — Registrant
- January 10, 2025 (date) — Report Date
- Delaware (jurisdiction) — State of Incorporation
- 1025 Willa Springs Dr. (address) — Principal Executive Offices
- Winter Springs, FL 32708 (address) — Principal Executive Offices Location
FAQ
What specific financial results are being reported by IRADIMED CORPORATION?
The provided text of the 8-K filing does not specify the exact financial results being reported, only that the filing pertains to 'Results of Operations and Financial Condition'.
What is the purpose of this 8-K filing for IRADIMED CORPORATION?
The purpose of this 8-K filing is to report on IRADIMED CORPORATION's results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K filing submitted?
The filing was submitted on January 10, 2025.
What is IRADIMED CORPORATION's principal executive office address?
IRADIMED CORPORATION's principal executive office is located at 1025 Willa Springs Dr., Winter Springs, FL 32708.
What is the SIC code for IRADIMED CORPORATION?
The Standard Industrial Classification (SIC) code for IRADIMED CORPORATION is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-01-10 12:15:19
Key Financial Figures
- $0.0001 — h registered: Common stock, par value $0.0001 IRMD NASDAQ Capital Market Item 2
Filing Documents
- irmd-20250110x8k.htm (8-K) — 32KB
- irmd-20250110xex99d1.htm (EX-99.1) — 22KB
- irmd-20250110xex99d1001.gif (GRAPHIC) — 11KB
- 0001558370-25-000117.txt ( ) — 189KB
- irmd-20250110.xsd (EX-101.SCH) — 3KB
- irmd-20250110_lab.xml (EX-101.LAB) — 15KB
- irmd-20250110_pre.xml (EX-101.PRE) — 10KB
- irmd-20250110x8k_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 10, 2025, iRadimed Corporation issued a press release (the "Press Release") announcing its preliminary unaudited revenues for the fourth quarter 2024 and full-year 2024. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. Furthermore, such information, including Exhibit 99.1, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated January 10, 2025. 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IRADIMED CORPORATION Date: January 10, 2025 By: /s/ John Glenn Name: John Glenn Title: Chief Financial Officer